Summary
44.93 1.77(4.09%)09/16/2024
Omnicell, Inc. (OMCL)
Omnicell, Inc. (OMCL)
Key Facts
| 1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years | All Time |
| 4.09 | 1.10 | 5.58 | 61.08 | 63.54 | -16.57 | -37.96 | 412.84 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1
| Trading Data | ||
| Close | 44.93 | |
| Open | 43.15 | |
| High | 45.06 | |
| Low | 43.07 | |
| Volume | 447,354 | |
| Change | 1.77 | |
| Change % | 4.09 | |
| Avg Volume (20 Days) | 345,664 | |
| Volume/Avg Volume (20 Days) Ratio | 1.29 | |
| 52 Week Range | 25.13 - 56.05 | |
| Price vs 52 Week High | -19.85% | |
| Price vs 52 Week Low | 78.77% | |
| Range | 4.11 | |
| Gap Up/Down | -0.67 | |
Fundamentals | ||
| Market Capitalization (Mln) | 2,064 | |
| EBIDTA | 28,217,000 | |
| PE Ratio | 0.0000 | |
| PEG Ratio | 2.2800 | |
| WallStreet Target Price | 34.33 | |
| Book Value | 25.8820 | |
| Earnings Per Share | -0.4600 | |
| EPS Estimate Current Quarter | -0.0900 | |
| EPS Estimate Next Quarter | 0.2400 | |
| EPS Estimate Current Year | 1.1200 | |
| EPS Estimate Next Year | 1.4300 | |
| Diluted EPS (TTM) | -0.4600 | |
| Revenues | ||
| Profit Marging | -0.0191 | |
| Operating Marging (TTM) | -0.0759 | |
| Return on asset (TTM) | -0.0084 | |
| Return on equity (TTM) | -0.0181 | |
| Revenue TTM | 1,102,633,984 | |
| Revenue per share TTM | 24.2750 | |
| Quarterly Revenue Growth (YOY) | -0.1530 | |
| Quarterly Earnings Growth (YOY) | -0.6760 | |
| Gross Profit (TTM) | 596,705,000 | |
| Dividends | ||
| Dividend Share | 0.0000 | |
| Dividend Yield | ||
| Valuations | ||
| Trailing PE | 0.0000 | |
| Forward PE | 29.4985 | |
| Price Sales (TTM) | 0.0000 | |
| Price Book (MRQ) | 1.0506 | |
| Revenue Enterprise Value | 1.2060 | |
| EBITDA Enterprise Value | 22.7940 | |
| Shares | ||
| Shares Outstanding | 45,923,500 | |
| Shares Float | 45,234,180 | |
| Shares Short | 0 | |
| Shares Short (Prior Month) | 0 | |
| Shares Ratio | 0.00 | |
| Short Outstanding (%) | 0.00 | |
| Short Float (%) | 0.08 | |
| Insider (%) | 1.47 | |
| Institutions (%) | 98.17 | |
09/11 10:02 EST - zacks.com
Should You Continue to Retain OMCL Stock in Your Portfolio Now?
Omnicell is well-placed for growth in the upcoming quarters owing to its progress in achieving the Autonomous Pharmacy goal.
Should You Continue to Retain OMCL Stock in Your Portfolio Now?
Omnicell is well-placed for growth in the upcoming quarters owing to its progress in achieving the Autonomous Pharmacy goal.
08/28 13:21 EST - zacks.com
Earnings Estimates Moving Higher for Omnicell (OMCL): Time to Buy?
Omnicell (OMCL) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Earnings Estimates Moving Higher for Omnicell (OMCL): Time to Buy?
Omnicell (OMCL) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
08/21 10:05 EST - zacks.com
Omnicell (OMCL) Introduces Central Med Automation Service
Omnicell (OMCL) has come up with a subscription-based solution named Central Med Automation Service. The solution is expected to improve inventory visibility, scalability and patient safety.
Omnicell (OMCL) Introduces Central Med Automation Service
Omnicell (OMCL) has come up with a subscription-based solution named Central Med Automation Service. The solution is expected to improve inventory visibility, scalability and patient safety.
08/20 16:30 EST - businesswire.com
Omnicell Announces Central Med Automation Service
FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell Announces Central Med Automation Service.
Omnicell Announces Central Med Automation Service
FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell Announces Central Med Automation Service.
08/04 01:49 EST - seekingalpha.com
Omnicell, Inc. (OMCL) Q2 2024 Earnings Call Transcript
Omnicell, Inc. (NASDAQ:OMCL ) Q2 2024 Earnings Conference Call August 1, 2024 8:30 AM ET Company Participants Kathleen Nemeth - Senior Vice President Randall Lipps - Founder, Chairman, President and CEO Nchacha Etta - Executive Vice President and CFO Conference Call Participants Stan Berenshteyn - Wells Fargo Scott Schoenhaus - KeyBanc Matt Hewitt - Craig-Hallum Capital Group David Larsen - BTIG Bill Sutherland - The Benchmark Company Anna Kruszenski - Barclays Allen Lutz - Bank of America Jessica Tassan - Piper Sandler Anne Samuel - JPMorgan Operator Good morning and thank you for standing by. My name is Aaron, and I will be your conference operator for today.
Omnicell, Inc. (OMCL) Q2 2024 Earnings Call Transcript
Omnicell, Inc. (NASDAQ:OMCL ) Q2 2024 Earnings Conference Call August 1, 2024 8:30 AM ET Company Participants Kathleen Nemeth - Senior Vice President Randall Lipps - Founder, Chairman, President and CEO Nchacha Etta - Executive Vice President and CFO Conference Call Participants Stan Berenshteyn - Wells Fargo Scott Schoenhaus - KeyBanc Matt Hewitt - Craig-Hallum Capital Group David Larsen - BTIG Bill Sutherland - The Benchmark Company Anna Kruszenski - Barclays Allen Lutz - Bank of America Jessica Tassan - Piper Sandler Anne Samuel - JPMorgan Operator Good morning and thank you for standing by. My name is Aaron, and I will be your conference operator for today.
08/02 10:26 EST - zacks.com
Omnicell (OMCL) Q2 Earnings Top Estimates, Margins Down
Omnicell's (OMCL) Q2 results outpace expectations despite a challenging customer environment.
Omnicell (OMCL) Q2 Earnings Top Estimates, Margins Down
Omnicell's (OMCL) Q2 results outpace expectations despite a challenging customer environment.
08/01 08:45 EST - zacks.com
Omnicell (OMCL) Surpasses Q2 Earnings and Revenue Estimates
Omnicell (OMCL) came out with quarterly earnings of $0.51 per share, beating the Zacks Consensus Estimate of $0.16 per share. This compares to earnings of $0.57 per share a year ago.
Omnicell (OMCL) Surpasses Q2 Earnings and Revenue Estimates
Omnicell (OMCL) came out with quarterly earnings of $0.51 per share, beating the Zacks Consensus Estimate of $0.16 per share. This compares to earnings of $0.57 per share a year ago.
07/25 11:07 EST - zacks.com
Omnicell (OMCL) Expected to Beat Earnings Estimates: Should You Buy?
Omnicell (OMCL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Omnicell (OMCL) Expected to Beat Earnings Estimates: Should You Buy?
Omnicell (OMCL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
07/24 07:50 EST - investorplace.com
3 Russell 2000 Stocks to Buy at a 52-week Low in July
The Russell 2000 index tracks the performance of small-to-mid capitalization stocks. If anyone has been watching this captivating index, they would have seen a stark divergence between small-to-mid-cap and large-cap returns.
3 Russell 2000 Stocks to Buy at a 52-week Low in July
The Russell 2000 index tracks the performance of small-to-mid capitalization stocks. If anyone has been watching this captivating index, they would have seen a stark divergence between small-to-mid-cap and large-cap returns.
07/03 12:41 EST - zacks.com
Omnicell (OMCL) Banks on Product Launches, Global Growth
Omnicell (OMCL) remains a key player in automating and modernizing global medication management infrastructure.
Omnicell (OMCL) Banks on Product Launches, Global Growth
Omnicell (OMCL) remains a key player in automating and modernizing global medication management infrastructure.
06/10 09:36 EST - zacks.com
Here's Why Omnicell (OMCL) Should be in Your Portfolio Now
A robust Advanced Services portfolio and strategic restructuring initiatives bode well for Omnicell (OMCL).
Here's Why Omnicell (OMCL) Should be in Your Portfolio Now
A robust Advanced Services portfolio and strategic restructuring initiatives bode well for Omnicell (OMCL).
06/03 12:41 EST - zacks.com
Omnicell (OMCL) Gains From New Offerings Amid Cost Woes
With the EnlivenHealth platform, Omnicell (OMCL) is gaining momentum with cross-selling and up-selling communication solutions to existing customers.
Omnicell (OMCL) Gains From New Offerings Amid Cost Woes
With the EnlivenHealth platform, Omnicell (OMCL) is gaining momentum with cross-selling and up-selling communication solutions to existing customers.
05/06 16:23 EST - businesswire.com
Omnicell Supports Global Charity Mercy Ships with Pharmacy Technology Donation
FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell Supports Global Charity Mercy Ships with Pharmacy Technology Donation.
Omnicell Supports Global Charity Mercy Ships with Pharmacy Technology Donation
FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell Supports Global Charity Mercy Ships with Pharmacy Technology Donation.
05/06 09:06 EST - zacks.com
Omnicell (OMCL) Q1 Earnings Top Estimates, Revenues Down Y/Y
Omnicell (OMCL) outpaces expectations in the first quarter of 2024 in a challenging customer environment.
Omnicell (OMCL) Q1 Earnings Top Estimates, Revenues Down Y/Y
Omnicell (OMCL) outpaces expectations in the first quarter of 2024 in a challenging customer environment.
05/03 16:01 EST - businesswire.com
Omnicell to Present at the BofA Securities 2024 Health Care Conference
FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell to Present at the BofA Securities 2024 Health Care Conference.
Omnicell to Present at the BofA Securities 2024 Health Care Conference
FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell to Present at the BofA Securities 2024 Health Care Conference.
05/02 14:22 EST - seekingalpha.com
Omnicell, Inc. (OMCL) Q1 2024 Earnings Call Transcript
Omnicell, Inc. (NASDAQ:OMCL ) Q1 2024 Earnings Conference Call May 2, 2024 8:30 AM ET Company Participants Kathleen Nemeth – Senior Vice President-Investor Relations Randall Lipps – Founder, Chairman, President and Chief Executive Officer Nchacha Etta – Executive Vice President and Chief Financial Officer Conference Call Participants Stan Berenshteyn – Wells Fargo Matt Hewitt – Craig-Hallum Scott Schoenhaus – KeyBanc Jessica Tassan – Piper Sandler Jenny Shen – BTIG Anna Kruszenski – Barclays Bill Sutherland – Benchmark Company Operator Good morning, ladies and gentlemen my name is John and I'll be you conference operator for today. Please note that today's call is being recorded.
Omnicell, Inc. (OMCL) Q1 2024 Earnings Call Transcript
Omnicell, Inc. (NASDAQ:OMCL ) Q1 2024 Earnings Conference Call May 2, 2024 8:30 AM ET Company Participants Kathleen Nemeth – Senior Vice President-Investor Relations Randall Lipps – Founder, Chairman, President and Chief Executive Officer Nchacha Etta – Executive Vice President and Chief Financial Officer Conference Call Participants Stan Berenshteyn – Wells Fargo Matt Hewitt – Craig-Hallum Scott Schoenhaus – KeyBanc Jessica Tassan – Piper Sandler Jenny Shen – BTIG Anna Kruszenski – Barclays Bill Sutherland – Benchmark Company Operator Good morning, ladies and gentlemen my name is John and I'll be you conference operator for today. Please note that today's call is being recorded.
05/02 09:46 EST - zacks.com
Omnicell (OMCL) Q1 Earnings and Revenues Top Estimates
Omnicell (OMCL) came out with quarterly earnings of $0.03 per share, beating the Zacks Consensus Estimate of a loss of $0.08 per share. This compares to earnings of $0.39 per share a year ago.
Omnicell (OMCL) Q1 Earnings and Revenues Top Estimates
Omnicell (OMCL) came out with quarterly earnings of $0.03 per share, beating the Zacks Consensus Estimate of a loss of $0.08 per share. This compares to earnings of $0.39 per share a year ago.
05/02 07:30 EST - businesswire.com
Omnicell Announces First Quarter 2024 Results
FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell Announces First Quarter 2024 Results.
Omnicell Announces First Quarter 2024 Results
FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell Announces First Quarter 2024 Results.
04/16 16:01 EST - businesswire.com
Omnicell Announces XT Amplify
FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell Announces XT Amplify: Multi-year Innovation Program Designed to Maximize Value and Outcomes for XT Automated Dispensing System.
Omnicell Announces XT Amplify
FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell Announces XT Amplify: Multi-year Innovation Program Designed to Maximize Value and Outcomes for XT Automated Dispensing System.
04/08 16:01 EST - businesswire.com
Omnicell to Release First Quarter 2024 Financial Results on May 2, 2024
FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell to Release First Quarter 2024 Financial Results on May 2, 2024.
Omnicell to Release First Quarter 2024 Financial Results on May 2, 2024
FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell to Release First Quarter 2024 Financial Results on May 2, 2024.